PNC Financial Services Group
TEVA icon

PNC Financial Services Group’s Teva Pharmaceuticals TEVA Stock Holding History

PNC Financial Services Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88M Buy
95,610
+46,206
+94% +$1.49M ﹤0.01% 883
2025
Q4 		$1.54M Buy
49,404
+715
+1% +$17.6K ﹤0.01% 1075
2025
Q3 		$984K Sell
48,689
-9,380
-16% -$165K ﹤0.01% 1260
2025
Q2 		$973K Sell
58,069
-1,578
-3% -$25.5K ﹤0.01% 1203
2025
Q1 		$917K Buy
59,647
+1,578
+3% +$28.2K ﹤0.01% 1199
2024
Q4 		$1.28M Sell
58,069
-1,186
-2% -$21.6K ﹤0.01% 1067
2024
Q3 		$1.07M Sell
59,255
-2,750
-4% -$48.1K ﹤0.01% 1144
2024
Q2 		$1.01M Sell
62,005
-6,025
-9% -$92.8K ﹤0.01% 1130
2024
Q1 		$960K Buy
68,030
+3,463
+5% +$43.7K ﹤0.01% 1175
2023
Q4 		$674K Sell
64,567
-6,391
-9% -$59.7K ﹤0.01% 1339
2023
Q3 		$724K Buy
70,958
+892
+1% +$8.31K ﹤0.01% 1277
2023
Q2 		$528K Sell
70,066
-8,310
-11% -$67.4K ﹤0.01% 1515
2023
Q1 		$694K Buy
78,376
+3,021
+4% +$29.9K ﹤0.01% 1337
2022
Q4 		$687K Buy
75,355
+1,266
+2% +$11K ﹤0.01% 1328
2022
Q3 		$599K Sell
74,089
-10,394
-12% -$91.9K ﹤0.01% 1405
2022
Q2 		$635K Sell
84,483
-34,593
-29% -$301K ﹤0.01% 1398
2022
Q1 		$1.12M Buy
119,076
+13,069
+12% +$109K ﹤0.01% 1177
2021
Q4 		$849K Sell
106,007
-1,458
-1% -$13.2K ﹤0.01% 1379
2021
Q3 		$1.05M Sell
107,465
-16,647
-13% -$156K ﹤0.01% 1167
2021
Q2 		$1.23M Sell
124,112
-4,812
-4% -$50.9K ﹤0.01% 1110
2021
Q1 		$1.49M Buy
128,924
+19,575
+18% +$224K ﹤0.01% 1008
2020
Q4 		$1.05M Sell
109,349
-4,903
-4% -$47K ﹤0.01% 1096
2020
Q3 		$1.03M Sell
114,252
-3,963
-3% -$41.9K ﹤0.01% 1034
2020
Q2 		$1.46M Sell
118,215
-6,091
-5% -$68.9K ﹤0.01% 893
2020
Q1 		$1.12M Sell
124,306
-3,843
-3% -$39.4K ﹤0.01% 931
2019
Q4 		$1.26M Sell
128,149
-4,063
-3% -$36.3K ﹤0.01% 997
2019
Q3 		$911K Buy
132,212
+8,725
+7% +$66.8K ﹤0.01% 1303
2019
Q2 		$1.14M Sell
123,487
-33,088
-21% -$399K ﹤0.01% 1231
2019
Q1 		$2.46M Sell
156,575
-694
-0.4% -$12.2K ﹤0.01% 962
2018
Q4 		$2.43M Sell
157,269
-25,638
-14% -$526K ﹤0.01% 930
2018
Q3 		$3.94M Sell
182,907
-4,777
-3% -$111K ﹤0.01% 833
2018
Q2 		$4.56M Sell
187,684
-25,571
-12% -$521K ﹤0.01% 784
2018
Q1 		$3.64M Sell
213,255
-38,619
-15% -$754K ﹤0.01% 835
2017
Q4 		$4.77M Sell
251,874
-118,805
-32% -$1.79M ﹤0.01% 748
2017
Q3 		$6.52M Sell
370,679
-156,274
-30% -$3.52M 0.01% 611
2017
Q2 		$17.5M Sell
526,953
-91,015
-15% -$2.82M 0.02% 421
2017
Q1 		$19.8M Sell
617,968
-107,671
-15% -$3.67M 0.02% 397
2016
Q4 		$26.3M Sell
725,639
-255,548
-26% -$10.2M 0.03% 350
2016
Q3 		$45.1M Sell
981,187
-115,401
-11% -$6.02M 0.05% 268
2016
Q2 		$55.1M Sell
1,096,588
-587,702
-35% -$31.3M 0.06% 230
2016
Q1 		$90.1M Sell
1,684,290
-38,962
-2% -$2.29M 0.11% 167
2015
Q4 		$113M Buy
1,723,252
+175,900
+11% +$10.9M 0.13% 144
2015
Q3 		$87.4M Buy
1,547,352
+189,976
+14% +$12.3M 0.1% 167
2015
Q2 		$80.2M Sell
1,357,376
-46,633
-3% -$2.88M 0.09% 184
2015
Q1 		$87.5M Buy
1,404,009
+69,178
+5% +$4.02M 0.1% 177
2014
Q4 		$76.8M Buy
1,334,831
+7,819
+0.6% +$436K 0.08% 190
2014
Q3 		$71.3M Buy
1,327,012
+316,120
+31% +$16.7M 0.08% 187
2014
Q2 		$53M Sell
1,010,892
-74,408
-7% -$3.8M 0.07% 208
2014
Q1 		$57.3M Sell
1,085,300
-4,371
-0.4% -$202K 0.08% 195
2013
Q4 		$43.7M Sell
1,089,671
-143,231
-12% -$5.64M 0.06% 214
2013
Q3 		$46.6M Buy
1,232,902
+15,032
+1% +$586K 0.07% 202
2013
Q2 		$47.7M Buy
+1,217,870
New +$47.4M 0.07% 193

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's TEVA Position: Q1 2026 in Review

PNC Financial Services Group increased its Teva Pharmaceuticals (TEVA) stake by 94% in Q1 2026, buying an estimated $1.49M and bringing the position to 95,610 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #883.

PNC Financial Services Group first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q4 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • PNC Financial Services Group held 95,610 shares of Teva Pharmaceuticals worth $2.88M as of Q1 2026.
  • PNC Financial Services Group bought 46,206 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.49M.
  • Teva Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #883 holding.
  • PNC Financial Services Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Teva Pharmaceuticals position peaked at $113M in Q4 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.